WMCC Radiation Oncology Program Achieves Reaccreditation with Distinction
West Michigan Cancer Center has earned a prestigious four-year reaccreditation by the American College of Radiation Oncology (ACRO), coupled with an outstanding Special Distinction in Stereotactic Radiotherapy.
Mazen Mislmani, MD, division chief, leads WMCC’s radiation oncology program, which has now achieved a distinction shared by only two other practices nationwide.
“The ACRO accreditation process represents a commitment to upholding the highest standards in radiation oncology,” said Dr. Mislmani. “This voluntary effort involves a thorough evaluation of our program by esteemed professionals who set the benchmark for quality.” Dr. Mislmani emphasized that rigorous audits ensure adherence to these precise standards. “In our pursuit of this recognition, WMCC underwent extensive peer reviews, including months-long assessments of patient care, safety measures, technological advancements, and on-site evaluations covering staffing, quality assurance, safety protocols, and operational workflows,” he added.
Accreditation is critical to the mission at WMCC as it signifies achievement in the areas of quality and patient safety as well as recognition by peers in the field of radiation oncology. “We know that a diagnosis of cancer is a life- changing experience for patients and their loved ones,” said Bridget VandenBussche, CPHRM, WMCC executive director. “We want our patients to know that the treatment they are receiving is being delivered at a high quality and safe organization. I could not be prouder of the entire team at WMCC.”
The Special Distinction is a peer-crafted program designed to honor practices excelling in Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiosurgery (SRS) treatments. These treatments are used for specific disease sites including genitourinary, intracranial and central nervous system, liver, lung, pancreas and spine. “This recognition affirms the dedication of our entire team at WMCC to continually improve and embrace new technology to ensure the best outcomes for our patients,” said Renu Sharma, MS, WMCC director of medical physics.
